NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021.

Nadeem R. Abu Rustum,Catheryn M. Yashar,Kristin A. Bradley,Susana M. Campos,Junzo Chino,Hye Sook Chon,Christina Chu,David E. Cohn,Marta A. Crispens,Shari Damast,Elisabeth Diver,Christine M. Fisher,Peter J. Frederick,David K. Gaffney,Suzanne George,Robert L. Giuntoli,Ernest S. Han,Brooke E. Howitt,Warner K. Huh,Jayanthi S. Lea,Andrea Mariani,David G. Mutch,Larissa Nekhlyudov,Mirna B. Podoll,Steven W Remmenga,R. Kevin Reynolds,Ritu Salani,Rachel C. Sisodia,Pamela T. Soliman,Edward J Tanner,Stefanie Ueda,Renata R. Urban,Stephanie L. Wethington,Emily Wyse,Kristine M. Zanotti,Nicole R. McMillian,Angela D Motter

NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021.

2021

The NCCN Guidelines for Uterine Neoplasms provide recommendations for diagnostic workup, clinical staging, and treatment options for patients with endometrial cancer or uterine sarcoma. These NCCN Guidelines Insights focus on the recent addition of molecular profiling information to aid in accurate diagnosis, classification, and treatment of uterine sarcomas.

Keywords:

Internal medicine
MEDLINE
Uterine sarcoma
Endometrial cancer
Oncology
Medicine
treatment options
Uterine Neoplasm

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations